The cascade of care for Australians living with chronic hepatitis B: Measuring access to diagnosis, management and treatment

Australian and New Zealand Journal of Public Health

Volumn 39, Issue 3, 2015, Pages 255-259

  Allard, Nicole L ^a,b   MacLachlan, Jennifer H ^a,b   Cowie, Benjamin C ^a,b  

^a PETER DOHERTY INSTITUTE FOR INFECTION AND IMMUNITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

cascade of care; epidemiology; health systems; hepatitis B; liver cancer

Indexed keywords

ANTIVIRUS AGENT;

AUSTRALIA; COST OF ILLNESS; DISEASE MANAGEMENT; ECONOMICS; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE DISPARITY; HEALTH SURVEY; HEPATITIS B, CHRONIC; HUMAN; MALE; MASS SCREENING; ORGANIZATION AND MANAGEMENT; PREVALENCE; PROCEDURES; PUBLIC HEALTH; RISK FACTOR;

ANTIVIRAL AGENTS; AUSTRALIA; COST OF ILLNESS; DELIVERY OF HEALTH CARE; DISEASE MANAGEMENT; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEALTHCARE DISPARITIES; HEPATITIS B, CHRONIC; HUMANS; MALE; MASS SCREENING; POPULATION SURVEILLANCE; PREVALENCE; PUBLIC HEALTH; RISK FACTORS;

EID: 84930460963     PISSN: 13260200     EISSN: 17536405     Source Type: Journal    
DOI: 10.1111/1753-6405.12345     Document Type: Article

References (39)

1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al., Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380 (9859): 2095-128.
2. MacLachlan JH, Allard N, Towell V, Cowie BC,. The burden of chronic hepatitis B virus infection in Australia, 2011. Aust N Z J Public Health. 2013; 37 (5): 416-22.
3. Nguyen VT, Amin J, Law MG, Dore GJ,. Predictors and survival in hepatitis B-related hepatocellular carcinoma in New South Wales, Australia. J Gastroenterol Hepatol. 2009; 24 (3): 436-42.
4. Condon JR, Barnes T, Cunningham J, Armstrong BK,. Long-term trends in cancer mortality for Indigenous Australians in the Northern Territory. Med J Aust. 2004; 180 (10): 504-7.
5. Australian Institute of Health and Welfare. Cancer Survival and Prevalence in Australia: Period Estimates from 1982 to 2010. Canberra (AUST): AIHW; 2012.
6. MacLachlan JH, Cowie BC,. Liver cancer is the fastest increasing cause of cancer death in Australians. Med J Aust. 2012; 197 (9): 492-3.
7. Chen CJ, Yang HI,. Natural history of chronic hepatitis B REVEALed. J Gastroenterol Hepatol. 2011; 26 (4): 628-38.
8. Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, et al., Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006; 295 (1): 65-73.
9. Liaw Y, Kao J, Piratvisuth T, Chan H, Chien R, Liu C, et al., Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2012 update. Hepatol Int. 2012; 6: 531-61.
10. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol. 2012; 57 (1): 167-85.
11. Zhang BH, Yang BH, Tang ZY,. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol. 2004; 130 (7): 417-22.
12. Wong N, Haydon A, Kemp W, Wijeratne P, Roberts S,. Improved survival trend of patients with hepatocellular carcinoma at an Australian tertiary hospital between 1995-2009. Intern Med J. 2013; 43 (2): 197-203.
13. Papatheodoridis GV, Lampertico P, Manolakopoulos S, Lok A,. Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: A systematic review. J Hepatol. 2010; 53 (2): 348-56.
14. Robotin MC, Kansil M, Howard K, George J, Tipper S, Dore GJ, et al., Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening. J Hepatol. 2009; 50 (5): 990-8.
15. Zoulim F, Locarnini S,. Hepatitis B virus resistance to nucleos(t)ide analogues. Gastroenterology. 2009; 137 (5): 1593-608 e2.
16. Lavanchy D,. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004; 11 (2): 97-107.
17. Robotin MC, Kansil MQ, George J, Howard K, Tipper S, Levy M, et al., Using a population-based approach to prevent hepatocellular cancer in New South Wales, Australia: Effects on health services utilisation. BMC Health Serv Res. 2010; 10: 215.
18. Hutton DW, Tan D, So SK, Brandeau ML,. Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B. Ann Intern Med. 2007; 147 (7): 460-9.
19. Cohen C, Holmberg SD, McMahon BJ, Block JM, Brosgart CL, Gish RG, et al., Is chronic hepatitis B being undertreated in the United States? J Viral Hepat. 2011; 18 (6): 377-83.
20. Department of Health. Second National Hepatitis B Strategy 2014-2017. Canberra (AUST): Commonwealth of Australia; 2014.
21. Department of Health & Human Services. HIV/AIDS Care Continuum [Internet]. United States Government; 2013 [cited 2014 Aug]. Available from: http://aids.gov/federal-resources/policies/care-continuum/
22. Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ,. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011; 52 (6): 793-800.
23. Afdhal NH, Zeuzem S, Schooley RT, Thomas DL, Ward JW, Litwin AH, et al., The new paradigm of hepatitis C therapy: Integration of oral therapies into best practices. J Viral Hepat. 2013; 20 (11): 745-60.
24. Kirby Institute. HIV in Australia Annual Surveillance Report 2014 Supplement. Sydney (AUST): University of New South Wales; 2014.
25. Hall R,. Notifiable diseases surveillance, 1917 to 1991. Commun Dis Intell. 1993; 17 (11): 226-36.
26. MacLachlan JH, Cowie BC,. Hepatitis B Mapping Project: Estimates of CHB Prevalence and Cultural and Linguistic Diversity by Medicare Local-National Report 2011. Darlinghurst (AUST): Australasian Society for HIV Medicine and Victorian Infectious Diseases Reference Laboratory; 2013.
27. Ellard J, Wallace J,. Stigma, Discrimination and Hepatitis B: A review of Current Research. Melbourne (AUST): La Trobe University Australian Research Centre in Sex Health and Society; 2013.
28. Olsen A, Wallace J, Maher L,. Responding to Australia's National Hepatitis B Strategy 2010-13: Gaps in knowledge and practice in relation to Indigenous Australians. Aust J Prim Health. 2013; 20 (2): 134-42.
29. Guirgis M, Nusair F, Bu YM, Yan K, Zekry AT,. Barriers faced by migrants in accessing healthcare for viral hepatitis infection. Intern Med J. 2012; 42 (5): 491-6.
30. Dev A, Nguyen JNH, Munafo L, Hardie E, Iacono L,. Chronic hepatitis B-a clinical audit of GP management. Aust Fam Physician. 2011; 40 (7): 533-8.
31. Wallace J, Hajarizadeh B, Richmond J, McNally S,. Challenges in managing patients in Australia with chronic hepatitis B: The General Practitioners' perspective. Aust N Z J Public Health. 2013; 37 (5): 405-10.
32. Wallace J, Pitts M, McNally S, Ward J, Nakata Y, Fagan P,. A Situational Analysis of Chronic Hepatitis B in the Torres Strait. Melbourne (AUST): La Trobe University Australian Research Centre in Sex Health and Society; 2011.
33. Williams S, Vally H, Fielding J, Cowie B,. Hepatitis B prevention in Victoria, Australia-the potential to protect. Euro Surveill. 2011; 16 (22):pii=19879.
34. Giles ML, Grace R, Tai A, Michalak K, Walker SP,. Prevention of mother-to-child transmission of hepatitis B virus (HBV) during pregnancy and the puerperium: Current standards of care. Aust N Z J Obstet Gynaecol. 2013; 53 (3): 231-5.
35. Guirgis M, Zekry A, Yan K, Bu YM, Lee A,. Chronic hepatitis B infection in an Australian antenatal population: Seroprevalence and opportunities for better outcomes. J Gastroenterol Hepatol. 2009; 24 (6): 998-1001.
36. Jimenez G, Alex G, Paxton G, Connell TG, Hardikar W,. B alert: Hepatitis B virus infection in children in Victoria. J Paediatr Child Health. 2013; 49 (3): E213-6.
37. Turnour CE, Cretikos MA, Conaty SJ,. Prevalence of chronic hepatitis B in South Western Sydney: Evaluation of the country of birth method using maternal seroprevalence data. Aust N Z J Public Health. 2011; 35 (1): 22-6.
38. Cowie B, Karapanagiotidis T, Enriquez A, Kelly H,. Markers of hepatitis B virus infection and immunity in Victoria, Australia, 1995 to 2005. Aust N Z J Public Health. 2010; 34 (1): 72-8.
39. Williams S, Vally H, Fielding J, Cowie B,. Chronic hepatitis B surveillance in Victoria, 1998-2008: Instituting a 21st century approach to an old disease. Aust N Z J Public Health. 2011; 35 (1): 16-21.